Advisor Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$14.9M Buy
99,910
+2,099
+2% +$288K 0.1% 181
2019
Q3
$12.1M Sell
97,811
-21,436
-18% -$2.85M 0.09% 203
2019
Q2
$16.8M Buy
119,247
+3,827
+3% +$528K 0.13% 140
2019
Q1
$17.4M Buy
115,420
+27,956
+32% +$4.02M 0.14% 130
2018
Q4
$10.9M Sell
87,464
-8,313
-9% -$1.14M 0.11% 167
2018
Q3
$15.2M Buy
95,777
+47,197
+97% +$7.14M 0.15% 125
2018
Q2
$6.8M Buy
48,580
+27,330
+129% +$3.75M 0.09% 196
2018
Q1
$2.82M Buy
21,250
+2,692
+15% +$368K 0.04% 425
2017
Q4
$2.31M Buy
18,558
+3,428
+23% +$424K 0.03% 509
2017
Q3
$1.88M Buy
15,130
+756
+5% +$89.5K 0.03% 529
2017
Q2
$1.64M Buy
14,374
+941
+7% +$101K 0.03% 548
2017
Q1
$1.42M Sell
13,433
-10,801
-45% -$1.08M 0.03% 573
2016
Q4
$2.2M Buy
24,234
+1,931
+9% +$181K 0.05% 401
2016
Q3
$2.22M Buy
22,303
+556
+3% +$54.6K 0.05% 372
2016
Q2
$1.94M Buy
+21,747
New +$2M 0.05% 388

Other funds holding FBT

Advisor Group's FBT Position: Q4 2019 in Review

Advisor Group increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 2.1% in Q4 2019, buying an estimated $288K and bringing the position to 99,910 shares worth $14.9M. The position accounts for 0.1% of the portfolio, ranked #181.

Advisor Group first reported a position in FBT in Q2 2016 and has held it in 15 quarters since. The position peaked at $17.4M in Q1 2019. 210 funds tracked by Wall St. Rank hold FBT as of Q4 2019.

  • Advisor Group held 99,910 shares of First Trust NYSE Arca Biotechnology Index Fund worth $14.9M as of Q4 2019.
  • Advisor Group bought 2,099 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2019, an estimated $288K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.1% of Advisor Group's portfolio in Q4 2019, its #181 holding.
  • Advisor Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $17.4M in Q1 2019.
  • 210 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.